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Abstract
Background: The expansion and function of adipose tissue are important during the development of insulin
resistance and inflammation in obesity. Zinc dyshomeostasis is common in obese individuals. In the liver, zinc influx
transporter ZIP14, affects proliferation and glucose metabolism but the role of ZIP14 in adipose tissue is still
unknown. This study investigates ZIP14 gene expression in human adipose tissue before and after weight loss as
well as the regulation of ZIP14 during early adipogenesis.
Methods: Fourteen obese individuals were investigated before and after a 10 week weight loss intervention and
compared to 14 non-obese controls. Gene expressions of ZIP14 and peroxisome proliferator-activated receptor γ
(PPARγ) were measured in subcutaneous adipose tissue and correlated with metabolic and inflammatory markers.
Further, we investigated gene expression of ZIP14 and PPARγ during early adipogenesis of 3T3-L1 pre-adipocytes,
together with an in silico analysis of PPARγ binding motifs in the promoter sequence of ZIP14.
Results: ZIP14 was down-regulated in obese individuals compared to non-obese controls (p = 0.0007) and was
up-regulated after weight loss (p = 0.0005). Several metabolic markers of clinical importance, including body mass
index, triglyceride, and insulin resistance, were inversely correlated with ZIP14. During early adipogensis an
up-regulation of ZIP14 gene expression was found. PPARγ gene expression was positively correlated with the ZIP14
gene expression in both adipose tissue and during adipogenesis. However, in silico analysis revealed that the ZIP14
promoter does not contain PPARγ-binding motifs.
Conclusions: We hypothesize that ZIP14-mediated zinc influx might directly influence PPARγ activity and that ZIP14
may regulate expansion and function of adipose tissue and serve as a potential biomarker for metabolic stress.
Keywords: SLC39a14, ZIP14, Adipose tissue, Obesity, Adipogenesis
* Correspondence: tmj@biomed.au.dk
1Department of Biomedicine, Faculty of Health, Aarhus University, Aarhus,
Denmark
Full list of author information is available at the end of the article
© 2015 Maxel et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Maxel et al. BMC Obesity  (2015) 2:46 
DOI 10.1186/s40608-015-0076-y
Background
White adipose tissue is an active endocrine organ that
secretes a vast number of adipokines including inflam-
matory cytokines and adipose tissue is considered to be
the main contributor to the low-grade inflammation and
insulin resistance in obesity [1].
In addition to obesity-induced inflammation and insu-
lin resistance, obese individuals have an altered zinc
homeostasis and reduced levels of circulating zinc [2].
Serum zinc levels inversely correlate to insulin resistance
[3]. In obese individuals, low dietary zinc intake relates
to a disturbed lipid profile, a pronounced inflammatory
response, and increased insulin production [4]. Intracel-
lular zinc homeostasis is also important for adipose tis-
sue function. In rat adipocytes, intracellular zinc has
been shown to stimulate the insulin signaling pathway,
leading to increased glucose uptake, enhanced lipogen-
esis and reduced production of free fatty acids [5].
Two families of zinc transporters, SLC39A (ZIPs) and
SLC30A (ZnTs), control intracellular zinc influx and ef-
flux from intracellular compartments as well as between
the extracellular and intracellular environment [6]. Cur-
rently, 14 influx transporters (ZIP1–14) and ten efflux
transporters (ZnT1–10) have been identified [7, 8]. The
expression of the SLC39A family members ZIP1–8 and
their zinc-efflux controlling counterparts ZnT1–8 have
been examined in adipose tissue finding evidence that
intracellular zinc homeostasis is altered in obese individ-
uals compared with normal weight controls [9].
ZIP14 is a zinc- and iron-importing protein highly
expressed in liver and pancreatic tissue, but it is also
expressed in adipose tissue [10–12]. ZIP14 seems to have
an impact on glucose homeostasis and adipose tissue, as
ZIP14 knock-out mice shows an altered glucose homeo-
stasis with hypoglycemia, increased insulin and liver glu-
cose levels as well as increased adipose tissue [13]. Zinc is
essential for cell differentiation and proliferation and
ZIP14 has recently been shown to play an important role
in the differentiation of hepatocytes and chondrocytes
[13–18]. Moreover, ZIP14 displays a strong up-regulation
during the early differentiation of murine 3T3-L1 pre-
adipocytes into mature adipocytes, indicating a role for
this transporter in adipogenesis [12].
In adipose tissue, the cell formation by adipogenesis,
the formation of new adipocytes from precursor cells, is
believed to constitute a healthy form of tissue expansion
in contrast to hypertrophy of existing adipocytes [19].
The process is controlled by peroxisome proliferator-
activated receptor γ (PPARγ) through its functions as a
transcription factor, by which it regulates several genes
involved in lipid and glucose metabolism [20, 21].
Pharmacological targeting of PPARγ has been attempted
with the use of thiazolidinediones. Thiazolidinediones
stimulate PPARγ and is considered to promote the
formation of smaller adipocytes, known to be more sen-
sitive to insulin and less lipolytically active than large
hypertrophic adipocytes [22, 23].
The aim of this study was to examine the expression
of ZIP14 in vivo in human adipose tissue relating the ex-
pression of this gene to body weight and clinical relevant
markers of glucose and lipid metabolism, insulin resist-
ance and PPARγ, thereby investigating the potential role
for ZIP14 as a biomarker in metabolic diseases. We
looked at obese individuals before and after weight loss
as well as obese vs. non-obese individuals. Secondly, we
sought to confirm the up-regulation of ZIP14 in 3T3-L1
pre-adipocytes during early differentiation and investi-
gate the correlation with differentiation markers, includ-
ing PPARγ.
Methods
Participants and intervention in the weight loss study
The weight loss intervention study was performed at the
Research Laboratory of Aarhus University Hospital. The
study design and the assessment of clinical parameters
(anthropometrics, insulin resistance, and lipid profile)
have previously been described in detail [24]. The study
included male and female participants, as well as age-
and sex-matched non-obese controls. All participants
were of European descent.
In summary, the obese participants had a body mass
index (BMI) higher than 30 kg/m2. The non-obese con-
trols had a BMI of 21–27 kg/m2. Subjects taking medica-
tion known to affect adipose tissue metabolism and/or
with diagnosed type 2 diabetes were excluded from this
study. In the present study, we examined 14 healthy, but
obese, subjects (7 women and 7 men; age, 39 ± 7 years,
BMI, 37 ± 3 kg/m2) and 14 non-obese controls (7 women
and 7 men; age, 39 ± 9 years, BMI, 23 ± 2 kg/m2). The age
range was 22–49 years.
Clinical investigations were performed at baseline and
after 10 weeks (8 weeks of diet-induced weight loss
followed by a 2-week weight-stabilizing period, during
which the participants followed a normal diet adjusted
to their new weight). During the weight loss period, par-
ticipants followed a liquid, very low-calorie diet, which
consisted of 600 calories together with 200 g of fruit and
vegetables daily. Prior to clinical investigations, partici-
pants fasted overnight and refrained from excessive
physical exercise and alcohol consumption for a 24 h
period. The non-obese controls did not participate in
the weight loss intervention but were examined once.
This study was approved by the Central Denmark
Region Committees on Biomedical Research Ethics and
the Danish Data Protection Agency.
Anthropometrics (BMI, waist circumference, and hip
circumference) and body fat percentage (by bioimpe-
dance) were measured. Subcutaneous adipose tissue
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samples used for real-time PCR were obtained by lipo-
suction from the abdomen, just below the umbilicus.
Fasting blood samples were drawn from all participants
and analyzed by standard procedures at the Department
of Clinical Biochemistry, Aarhus University Hospital
(glucose and lipids), except for serum insulin concentra-
tions, which were measured by an ELISA (DAKO
K6219, Electra Box Diagnostics Aps, Rødovre, Denmark)
according to the manufacturer’s protocol. To evaluate
insulin resistance, the homeostasis model assessment
(HOMA) index was used (fasting serum insulin concen-
tration (μU/L) × fasting plasma glucose concentration
(mmol/L)/22.5) [25, 26]. The procedures were described
previously [24].
Details on how the measurements of interleukin (IL)-
6, leptin, and adiponectin in blood and tumor necrosis
factor (TNF)-α, IL-10, as well as leptin gene expressions
in adipose tissue are found and described in earlier stud-
ies [27, 28].
Measurement of zinc and iron in blood samples
Serum zinc (Zn), serum iron (Fe), serum ferritin, and
plasma transferrin were measured at the Department of
Clinical Biochemistry, Randers Hospital, Denmark using
a cobas system (COBASR, using the e601 module for fer-
ritin, otherwise the c501 module).
3T3-L1 cell culture and differentiation
Murine 3T3-L1 pre-adipocytes obtained from the
American Type Culture Collection (Manassas, VA, USA)
were cultured in 5 % CO2 in Dulbecco’s modified Eagle’s
medium (DMEM) (Sigma-Aldrich, Denmark) containing
25 mM glucose, 10 % calf serum (PAA Cell Culture
Company, Germany) and 1 % penicillin/streptomycin.
Cells were cultured until 100 % confluent in 24-well
plates. Two days after reaching confluency, cells were in-
duced to differentiate into mature adipocytes by culture
in DMEM containing 10 % fetal calf serum (Gibco,
Denmark), 1 % penicillin/streptomycin, 1 μg/ml insulin
(Sigma-Aldrich), 0.5 mM 3-isobutyl-1-methylxanthine
(Sigma-Aldrich), and 1 μM dexamethasone (Sigma-Aldrich)
[29]. Samples (n = 6 per group) were collected at 0, 1, 3, 6,
12, 24, and 48 h after differentiation began, which corre-
sponds to the early differentiation phase, during which cells
complete post-confluent mitosis to unwind DNA, thereby
allowing transcription factors to regulate genes and result-
ing in the formation of cells resembling mature adipocytes
[30]. Additional cells were grown until complete differenti-
ation at day 8 to confirm correct differentiation (n = 6). The
morphology of 3T3-L1 cells was examined throughout the
entire differentiation process (i.e., until day 8) using an
Olympus CKX41 camera and Olympus DP-Soft CVI ver-
sion 3.2 software. Differentiation was further confirmed by
measuring gene expression of the differentiation markers
PPARγ and fatty acid-binding protein 4 (A-FABP) [30, 31].
RNA extraction and real-time PCR
RNA was purified using TRIzol (Invitrogen, Denmark)
according to the manufacturer’s instructions and was
reverse-transcribed into cDNA using the ImProm-IITM
Reverse Transcription System (Promega, Denmark). Two
samples, one of 3T3-L1 cells and one of adipose tissue,
were discarded due to DNA contamination.
The primers used are listed in Additional file 1 (TAC)
[31, 32]. Quantitative real-time PCR was performed in
duplicate with IQ SYBR Green Supermix (Bio-Rad,
Denmark) in a MyiQ Single-Color Real-Time PCR
Detection System (Bio-Rad). The results were analyzed
with iQ™5 Optical System Software, version 2.0. Starting
quantities were calculated from a standard curve. Values
were normalized to the geomean of the housekeeping
genes. The GeNorm method was used to confirm the sta-
bility of the housekeeping genes [33]. Low density lipopro-
tein receptor-related protein 10 (LRP10) was specifically
used as a housekeeping gene in the human study because
of its known stability in human adipose tissue, which was
confirmed in this experiment as well [32].
In silico analysis of PPARγ-binding motifs in the promoter
sequence of ZIP14
In silico analysis to identify PPARγ-binding motifs (PPARγ,
PPARγ:RXRα, and (PPARγ:RXRα, PPARγ)) in the promoter




PCR data from adipose tissue are provided as the mean
starting quantity of (gene of interest/LRP10) ± standard
error of the mean (SEM). Data were considered normally
distributed through statistical analysis using the GraphPad
Prism 5 program and a paired t-test was used to detect
statistical difference between obese participants before
and after weight loss. An unpaired t-test was used to de-
tect statistical difference between the non-obese controls
and the obese participants before weight loss. The stand-
ard Pearson’s correlation was calculated to detect possible
correlations between ZIP14 gene expression, and meta-
bolic and inflammatory markers (adipokines) in obese in-
dividuals before weight loss and non-obese controls.
Likewise, possible correlations were tested between gene
expression of ZIP14 and zinc or iron concentrations
(transferrin, ferritin, total zinc, and total iron). A two-way
analysis of variance (ANOVA) was used to evaluate any ef-
fect of gender on gene expression of ZIP14, PPARγ1, or
PPARγ2 comparing obese before weight loss and non-
obese individuals.
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In vitro study
PCR data from 3T3-L1 cells are provided as the mean
starting quantity of (gene of interest/three housekeeping
genes) ± SEM. Data were considered normally distrib-
uted through statistical analysis. A one-way ANOVA was
performed, followed by the Newman-Keuls test if the re-
sult was significant, to detect statistically significant differ-
ences among the time points. The standard Pearson’s
correlation was calculated to detect correlations between
gene expression of the differentiation markers (PPARγ
and A-FABP) and that of ZIP14 during differentiation.
For all statistical analyses, a p-value ≤ 0.05 was consid-
ered significant and the statistical package GraphPad
Prism 5 was used for calculations.
Results
Part I: Human study. Expression of ZIP14 and PPARγ
in adipose tissue of obese individuals before and
after weight loss and comparisons with non-obese
individuals: correlations with anthropometric,
metabolic, and inflammatory markers
At baseline, all obese participants had a BMI higher than
30 kg/m2 (37 ± 3 kg/m2), while non-obese controls had a
BMI of 21–27 kg/m2 (23 ± 2 kg/m2). Comparisons of
baseline data showed the expected differences in waist/
hip ratio, body fat percentage, and glucose and lipid pro-
files between obese individuals and non-obese controls
(Table 1), see also [24].
Anthropometric and metabolic data improved after weight
loss
The obese individuals obtained a weight loss of 12.5 ±
3.4 kg on average and a significant reduction in BMI
from 37 ± 3 kg/m2 to 33 ± 3 kg/m2. The weight loss was
reflected by decreased body fat percentage (p < 0.0001)
as well as decreased waist/hip ratio (p < 0.0001).
Cholesterol (p = 0.0005) and low-density lipoprotein
(LDL; p = 0.0005) concentrations significantly decreased
after weight loss. The triglyceride concentration was only
significantly reduced in women (p = 0.0213), whereas
there was no change in the high-density lipoprotein
(HDL) concentration.
The fasting insulin concentration (p = 0.0002) and in-
sulin resistance (p = 0.0002) as judged by the HOMA
index were significantly reduced after weight loss, al-
though the glucose concentration did not change. An-
thropometric and metabolic data of the participants are
shown in Table 1, see also [24].
ZIP14 gene expression is significantly lower in obese
individuals than in non-obese individuals, and increases
markedly following weight loss
At baseline, ZIP14 gene expression was significantly
lower in obese individuals than in non-obese controls
(p = 0.0007). After weight loss, ZIP14 gene expression
significantly increased (p = 0.0005) (Fig. 1). Two-way
ANOVA showed no independent influence of gender
on ZIP14 gene expression (data not shown).
The expression patterns of PPARγ1 and ZIP14 are similar
The two main isoforms of PPARγ mRNA, namely, PPARγ1
and PPARγ2, were separately investigated. PPARγ1 gene ex-
pression was significantly lower in obese individuals than in
non-obese controls (p = 0.0016). After weight loss, PPARγ1
gene expression significantly increased (p = 0.0018) (Fig. 2a).
Gene expression of PPARγ2 did not significantly differ
(Fig. 2b).
Two-way ANOVA showed no effect of gender on the
gene expression of PPARγ1 or PPARγ2.
Total blood levels of zinc and iron are unaffected by body
weight
Levels of zinc and markers of iron homeostasis in blood
are significantly lower in women than in men (see also
Table 2) [34, 35]; therefore, we examined the two gen-
ders separately. At baseline, Zn, Fe, and transferrin con-
centrations did not differ between obese individuals and
non-obese controls (neither before nor after weight loss),
and weight loss did not significantly alter these concen-
trations in the obese individuals. The concentration of
ferritin was significantly higher in obese men compared
to non-obese men both before and after weight loss
(p = 0.0243 and p = 0.0332, respectively), but no significant
effect of a weight loss was found. The concentrations of
Zn, Fe, transferrin, and ferritin are shown in Table 2.
Gene expression of ZIP14 correlates with clinical signs of
metabolic dysfunction and PPARγ gene expression
There was a significant positive correlation between gene
expression of ZIP14 and that of PPARγ1 (p < 0.0001) and
PPARγ2 (p = 0.0487). In terms of clinical parameters,
ZIP14 gene expression was significantly inversely
correlated with all markers of obesity, namely, BMI
(p = 0.0012), waist/hip ratio (p = 0.0181), and body fat per-
centage (p = 0.0009). Moreover, ZIP14 gene expression was
inversely correlated with HOMA index (p = 0.0009), blood
glucose (p = 0.0324) and insulin (p = 0.0007). Further, there
was a significant positive correlation between ZIP14 gene
expression and HDL concentration (p = 0.0015), whereas
triglyceride concentration was significantly inversely corre-
lated with ZIP14 gene expression (p = 0.0041). There were
no significant correlations between ZIP14 gene expression
and LDL or cholesterol concentrations. Pearson’s r-values
and p-values are shown in Table 3.
There were no significant correlations between concen-
trations of Zn, Fe, transferrin, and ferritin with ZIP14 gene
expression (data not shown). All correlations included obese
individuals before weight loss and non-obese controls.
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ZIP14 gene expression in adipose tissue correlates with
several adipokines in adipose tissue and blood
As previously described [27, 28], in adipose tissue TNF-
α, IL-10, as well as leptin gene expression was signifi-
cantly higher in obese individuals than in non-obese
controls. IL-6 levels in blood however showed no signifi-
cant difference between obese and non-obese individ-
uals. Blood concentrations of leptin and adiponectin
were significantly higher and lower, respectively, in obese
individuals than in non-obese controls.
There was an inverse correlation between gene expres-
sion of ZIP14 and that of TNF-α, leptin, and IL-10 in
adipose tissue (p = 0.0241, p < 0.0001, and p = 0.0068, re-
spectively) and the level of leptin in blood (p = 0.0040)
(Table 4). ZIP14 gene expression showed no significant
correlations with IL-6 or adiponectin in blood. All corre-
lations included obese individuals before weight loss and
non-obese controls.
Part II: In vitro regulation of ZIP14 during the early
differentiation of 3T3-L1 cells
We investigated the gene expression of ZIP14 in 3T3-L1
pre-adipocytes during the early differentiation phase (0, 1,
3, 6, 12, 24 and 48 h after the induction of differentiation).
Up-regulation of A-FABP and PPARγ gene expression
confirms that 3T3-L1 cells differentiated into mature
adipocytes
A-FABP and PPARγ were chosen as adipocyte differenti-
ation markers [30, 31]. Both genes were significantly up-
Table 1 Metabolic data of obese and non-obese individuals
Obese individuals before weight loss Non-obese controls Obese individuals after weight loss
BMI (kg/m2) 37 (±3) 23 (±2) 33 (±3)
*** ***
Waist/hip ratio 1.0 (±0.09) 0.8 (±0.08) 0.9 (±0.08)
*** ***
Body fat percentage 42 (±6) 23 (±7) 38 (±6)
*** ***
Cholesterol (mmol/L) 5.4 (±1.1) 4.9 (±0.8) 4.9 (±0.8)
***
HDL (mmol/L) 1.1 (±0.2) 1.5 (±0.3) 1.1 (±0.2)
***
LDL (mmol/L) 3.4 (±0.8) 2.9 (±0.8) 2.9 (±0.6)
***
Triglyceride (mmol/L) 2.1 (±0.9) 1.1 (±0.4) 1.9 (±0.8)
***
Insulin (pmol/L) 92 (±28) 49 (±15) 67 (±32)
*** ***
Glucose (mmol/L) 5.8 (±0.5) 5.3 (±0.4) 5.6 (±0.2)
**
HOMA index 4.0 (±1.3) 1.9 (±0.6) 2.8 (±1.3)
*** ***
Anthropometric data, lipid profiles, and glucose homeostasis in blood from obese individuals before and after weight loss and from non-obese controls. Data are
presented as mean ± standard deviation (n = 14 per group). **, P < 0.01; ***, P < 0.001 compared with obese individuals before weight loss. BMI, body mass index;
HDL, high-density lipoprotein; HOMA, homeostasis model assessment; LDL, low-density lipoprotein
Fig. 1 Gene expression of ZIP14 in adipose tissue. Gene expression
of ZIP14 in adipose tissue from obese individuals before (Before) and
after (After) weight loss and from non-obese controls (Control). Data
are presented as the mean starting quantity of (ZIP14/LRP10) ± standard
error of the mean (n = 13–14 per group). ***, P < 0.001
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regulated 48 h after differentiation began and confirmed
differentiation (p < 0.01 compared with levels prior to
differentiation (0 h)) (Fig. 3) [31]. Microscopy analysis of
cells 8 days after initiating differentiation showed the
transformation of 3T3-L1 cells into mature adipocytes
compared with differentiation start (Additional file 2).
Gene expression of ZIP14 is up-regulated during early differ-
entiation and correlates with PPARγ
Gene expression of ZIP14 peaked 3 h after initiating dif-
ferentiation (Fig. 4). When correlating the gene expression
of ZIP14 with that of PPARγ at the time of the peak (3 h)
showed a significant positive correlation (p = 0.0143). No
correlation between ZIP14 and A-FABP was seen at this
time point. No significant correlations were found be-
tween ZIP14 gene expression and the two differentiations
markers before the peak (0–1 h), but after the peak both
differentiation markers, PPARγ and A–FABP, showed
significant positive correlations with ZIP14 (6–48 h)
(p = 0.0406 and p = 0.0484, respectively (Table 5).
Part III: In silico analysis of PPARγ-binding motifs in the
promoter sequence of ZIP14
To investigate the correlation between the gene expres-
sion patterns of ZIP14 and PPARγ in both human adipose
tissue and during differentiation, the promoter sequence
of ZIP14 was analyzed. MotifMap software did not find
evidence of the presence of any PPARγ-binding motifs
(PPARγ, PPARγ:RXRα, and (PPARγ:RXRα, PPARγ)) in the
promoter sequence of human or mouse ZIP14.
Discussion
The present study supports a role for ZIP14, a zinc and
iron transporter, in adipogenesis and adipose tissue
homeostasis. ZIP14 gene expression was significantly
lower in obese individuals than in non-obese controls.
After weight loss, ZIP14 gene expression significantly in-
creased, indicating that regulation of ZIP14 is related to
obesity and that this process is reversible. Our findings
indicate that gene expression of ZIP14 is associated with
that of PPARγ, which was shown in both the human adi-
pose tissue as well as in the 3T3-L1 pre-adipocytes dur-
ing differentiation in vitro. Furthermore, we linked the
expression of ZIP14 with several clinical markers of me-
tabolism, including BMI, lipid profile, glucose homeosta-
sis, and levels of inflammatory markers. Our results
support a link between altered zinc homeostasis and
metabolic disease, indicating that ZIP14 has a specific
role in adipose tissue function and is a potential bio-
marker of metabolic stress in adipose tissue.
Fig. 2 Gene expression of PPARγ1 and PPARγ2 in adipose tissue.
Gene expression of PPARγ1 (a) and PPARγ2 (b) in adipose tissue from
obese individuals before (Before) and after (After) weight loss and
from non-obese controls (Control). Data are presented as the mean
starting quantity of (gene of interest/LRP10) ± standard error of the
mean (n = 13–14 per group). **, P < 0.01
Table 2 Zinc and iron homeostatic markers in blood from obese and non-obese individuals
Obese individuals before weight loss Non-obese controls Obese individuals after weight loss
Women Men Women Men Women Men
Zn (μmol/L) 13.3 (±1.7) 14.3 (±1.3) 11.8 (±0.7)*** 13.3 (±0.1) 12.8 (±1.7) 14.5 (±1.4)
Fe (μmol/L) 17.4 (±5.5) 21.9 ( ±6.9) 15.8 (±5.2)** 22.7 (±5.1) 13.1 (±5.6) 18.8 (±5.2)
Ferritin (μg/L) 61 (±40)**** 247 (±105)* 49 (±43) 120 (±78) 69 (±51)*** 243 (±111)*
Transferrin (μmol/L) 36.0 (±3.6) 33.7 (±3.9) 34.4 (±6.8) 34.2 (±4.7) 33.6 (±3.3) 32.2 (±3.8)
Total Zn, Fe, ferritin, and transferrin concentrations in blood from obese individuals (before and after weight loss) and from non-obese controls. Data are
presented as mean ± standard deviation. *P < 0.05, obese individuals vs. non-obese controls of the same gender. **P < 0.05, ***P < 0.01, ****P < 0.001, when
comparing women vs men within the same weight group. No significant differences were found when comparing obese individuals before and after weight loss
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The down-regulation of ZIP14 found in obese individ-
uals in this study supports the notion that intracellular
zinc regulation is altered in adipose tissue from obese in-
dividuals. Similar findings were described by Smidt and
co-workers who investigated several zinc transporters of
both families (ZnT1-8 and ZIP1-8) and found the major-
ity of them to be down-regulated in obesity [9]. Both the
present study and the work of Smidt and co-workers
were performed on biopsies of fatty tissues in which a
degree of macrophage infiltration must be expected, es-
pecially in obese individuals [1]. The expression levels of
the macrophage markers CD68 and CD14 have previ-
ously been assessed in this study population and showed
a higher degree of macrophage infiltration in the obese
compared with the non-obese controls [28]. Altered
intracellular zinc regulation in macrophages might
therefore also affect the findings. An up-regulation of
ZIP14 has been shown in macrophages during an acute
inflammatory response [36] indicating a potential differ-
ence among cell types, however data from the in vitro
experiment in the 3T3-L1 cells supports a major role of
adipocytes in the down-regulation of ZIP14.
Recent studies suggest a function for ZIP14 in cell
proliferation and differentiation. At the cellular level,
ZIP14 over-expression enhances the proliferation of he-
patocytes and ZIP14 is up-regulated during liver regen-
eration in a murine model of partial hepatectomy, with a
concomitant increase in the hepatic zinc content, which
is not seen in ZIP14 knock-out mice [16]. Further evi-
dence of a role for ZIP14 in cell proliferation and differ-
entiation was found in investigations of bone formation
in ZIP14 knock-out mice, in which shortening of long
bones was described together with disturbed chondro-
cyte differentiation [18].
In the current study, ZIP14 was up-regulated during
the early differentiation of adipocytes, during which cells
undergo post-confluent mitotic cell division and DNA
unwinding, which allows transcriptions factors to regu-
late genes that induce further differentiation into mature
adipocytes. This indicates a function for ZIP14 protein
in adipogenesis, confirming the finding of Tominaga
et al. that ZIP14 expression peaks during the early dif-
ferentiation of 3T3-L1 cells [12].
Because of its regulation of DNA synthesis and mi-
tosis, zinc is essential for cell proliferation and differenti-
ation [14, 37]. In 3T3-L1 cells, zinc influx transiently
increases by 5-fold 24 h after the induction of differenti-
ation. This influx of zinc correlates with cell prolifera-
tion and seems to be essential for entry into S-phase of
the cell cycle [38]. It could therefore be speculated that
zinc influx (by ZIP14) is increased in dividing cells to
regulate adipogenesis, with elevated ZIP14 gene expres-
sion 3 h after the induction of differentiation, which cor-
responds to translation of RNA into protein, and a
subsequent peak in zinc ion transport at 24 h [38]. We
speculate that the decrease in ZIP14 gene expression oc-
curs through a negative feedback regulation involving
the metal-response element-binding transcription factor
1(MTF-1). MTF-1 is known to be induced upon increased
cytosolic zinc levels and has been shown to regulate
mRNA expression of another SLC39A transporter, ZIP10
in a negative manner in hepatocytes [39, 40].
To our best knowledge, the association between ZIP14
and PPARγ gene expression has not been previously in-
vestigated. In our experiments, ZIP14 and PPARγ ex-
pression appeared to be linked in both murine 3T3-L1
adipocytes and human adipose tissue. PPARγ is the main
regulator of adipogenesis, and mature adipocytes require
sustained PPARγ expression to remain in a differentiated
state [20]. PPARγ is a transcription factor that forms a
Table 4 Correlations between ZIP14 gene expression and the
gene expression and blood levels of adipokines
ZIP14 gene expression
TNF-α gene expression r = −0.44, p = 0.0241
Leptin gene expression r = −0.70, p < 0.0001
IL-10 gene expression r = −0.53, p = 0.0068
IL-6 (blood level) r = −0.31, p = 0.1059
Leptin (blood level) r = −0.54, p = 0.0040
Adiponectin (blood level) r = −0.05, p = 0.8127
Correlations between ZIP14 gene expression in adipose tissue and blood levels
and gene expression in adipose tissue of adipokines. Obese individuals before
weight loss and non-obese controls were included (n = 27). Pearson’s r-values
and p-values are shown. IL, interleukin; TNF, tumor necrosis factor
Table 3 Correlations between ZIP14 gene expression, PPARγ
gene expression, and metabolic markers
ZIP14 gene expression
PPARγ1 gene expression r = 0.68, p < 0.0001
PPARγ2 gene expression r = 0.38, p = 0.0487
BMI r = −0.59, p = 0.0012
Waist/hip ratio r = −0.45, p = 0.0181
Body fat percentage r = −0.60, p = 0.0009
Cholesterol r = −0.25, p = 0.2112
HDL r = 0.58, p = 0.0015
LDL r = −0.26, p = 0.1925
Triglyceride r = −0.53, p = 0.0041
Insulin r = −0.61, p = 0.0007
Glucose r = −0.41, p = 0.0324
HOMA index r = −0.60, p = 0.0009
Correlations between ZIP14 and PPARγ gene expression levels, anthropometric
data, lipid profiles, and glucose homeostasis from obese individuals before
weight loss and from non-obese controls (n = 27). Pearson’s r-values and
p-values are shown. BMI, body mass index; HDL, high-density lipoprotein;
HOMA, homeostasis model assessment; LDL, low-density lipoprotein; PPAR,
peroxisome proliferator-activated receptor
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heterodimer with retinoid X receptor-α, followed by
binding to peroxisome proliferator response elements in
the promoter regions of target genes involved in lipid
metabolism and adipogenesis [21]. Structurally, it re-
quires zinc to form two zinc finger-like motifs. These
motifs are responsible for binding to promoter regions
in target genes [41]. It could be speculated that PPARγ
controls ZIP14 through its function as a transcription
factor however our in silico analysis, did not support the
presence of any PPARγ-binding motifs in the promoter
sequence of ZIP14. As ZIP14 gene expression peaked
before PPARγ during early differentiation, an indirect
link between ZIP14 and PPARγ could be hypothesized
namely that the zinc imported by ZIP14 could affect
PPARγ activity. On the other hand: both PPARγ and
ZIP14 gene expression have been shown to be up-
regulated by pro-inflammatory cytokines [42, 43]. As ad-
ipocytes secrete a vast number of cytokines, including
TNF-α and IL-6, these inflammatory cytokines could
cause an increase in both ZIP14 and PPARγ expression
[44].
Two splice variants of PPARγ have been described in
human tissue, namely, PPARγ1 and PPARγ2. PPARγ1
mRNA is highly expressed in adipose tissue but is also
expressed in other tissues, whereas PPARγ2 is restricted
to adipose tissue [21]. We investigated these isoforms
separately in human adipose tissue because other studies
have found weight-dependent differences in gene expres-
sion of PPARγ1 and PPARγ2 in human adipocytes [45].
Gene expression of ZIP14 correlated with that of both
Table 5 Correlations between ZIP14 gene expression and the
gene expression of differentiation markers
PPARγ gene expression ZIP14 gene expression
0-1 h r = 0.44, p = 0.1481
3 h r = 0.90, p = 0.0143
6-48 h r = 0.43, p = 0.0406
A-FABP gene expression ZIP14 gene expression
0-1 h r = 0.42, p = 0.1692
3 h r = 0.38, p = 0.1205
6-48 h r = 0.42, p = 0.0484
Correlations between ZIP14 gene expression with PPARγ and A-FABP gene
expression during early differentiation of 3T3-L1 cells. Correlations are shown
before, during, and after the peak in ZIP14 gene expression, corresponding to
0–1 h, 3 h, and 6–48 h after differentiation start. Pearson’s r-values and
p-values are shown. A-FABP, fatty acid-binding protein 4; PPAR, peroxisome
proliferator-activated receptor
Fig. 4 Gene expression of ZIP14 in 3T3-L1 cells during the early differ-
entiation phase. Gene expression of ZIP14. Results are expressed as the
mean starting quantity of (ZIP14/three housekeeping genes) ± standard
error of the mean. Data are shown during the early differentiation
phase (0, 1, 3, 6, 12, 24 and 48 h after the induction of differentiation),
(n = 5–6 per group). *, P < 0.05
Fig. 3 Gene expression of differentiation markers in 3T3-L1 cells during the early differentiation phase. Gene expression of the differentiation
markers peroxisome proliferator-activated receptor γ (PPARγ) and fatty acid-binding protein 4 (A-FABP). Results are expressed as the mean starting
quantity of (gene of interest/three housekeeping genes) ± standard error of the mean. Data are shown during the early differentiation phase
(0, 1, 3, 6, 12, 24 and 48 h after the induction of differentiation), (n = 5–6 per group). *, P < 0.05; **, P < 0.01; ***, P < 0.001. Significant differences
are shown compared to undifferentiated cells (0 h)
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isoforms, but its correlation with PPARγ1 gene expres-
sion was strongest.
In the present study, subcutaneous abdominal adipose
tissue was investigated. Although this tissue is considered
to be healthier than visceral adipose tissue, it is still associ-
ated with metabolic risk factors such as increased BMI and
blood pressure and adverse glucose and lipid homeostasis
[46]. Notably, ZIP14 gene expression in this tissue was sig-
nificantly correlated with several metabolic markers includ-
ing anthropometric data (BMI, body fat percentage, and
waist/hip ratio), lipid metabolism (triglyceride and HDL
concentrations), and glucose metabolism (glucose concen-
tration, insulin concentration, and the HOMA index). This
indicates that ZIP14 and its regulation are linked to the
metabolic function of the body, with down-regulation in
obesity. Based on the present data, we cannot confirm any
causative relationship between ZIP14 and clinical parame-
ters. We can however speculate that since consistent corre-
lations were found by investigating this limited number of
individuals, there is a connection between ZIP14 and lipid
and glucose metabolism, indicating a role for ZIP14 as a
biomarker of metabolic stress in adipose tissue.
In support of this, ZIP14 down-regulation was corre-
lated with the expression of several cytokines produced
in unhealthy adipose tissue as part of the inflammatory
response in obesity, i.e., TNF-α and IL-10. Paradoxically,
other studies have shown that ZIP14 gene expression is
up-regulated in liver, muscle, and white adipose tissue
when a low-grade inflammatory state is induced in mice
by lipopolysaccharide stimulation, possibly through inter-
action with IL-6 [13, 47]. In the present study, ZIP14 gene
expression showed no significant correlation with the IL-6
levels in the blood. However, it should be noted that the
IL-6 expression levels of the obese individuals did not sig-
nificantly differ from the levels found in their non-obese
counterparts. Our findings may reflect a difference in
regulation of ZIP14 following an LPS induced- acute in-
flammatory state with a strong IL-6 response vs. the
chronic inflammation found in obesity. Tissue specific
pattern of inflammation and macrophage presence might
also play a role.
As expected, levels of the weight regulatory hormones
adiponectin and leptin were lower and higher, respect-
ively, in obese individuals than in non-obese controls
[48]. The levels of leptin in blood and adipose tissue
were inversely correlated with gene expression of ZIP14.
It has been known for many years that levels of zinc and
leptin are correlated. Several studies investigating
healthy, obese, or obese type 2 diabetic individuals have
shown an inverse correlation between plasma leptin and
zinc levels [49–51]. Our finding of an inverse correlation
between ZIP14 gene expression and the level of leptin
suggests a complex relationship between leptin and
zinc homeostasis that involves intracellular zinc
homeostasis in adipose tissue, not just total zinc
levels in blood.
No correlation was found between ZIP14 gene expres-
sion and the total zinc level in blood. Although several
studies confirmed that the circulating zinc level is re-
duced in obese individuals, zinc levels appear to be
highly variable, even in obese individuals [52–54]. In the
current study, the zinc concentration did not signifi-
cantly differ between obese individuals and non-obese
controls. This confirms a report that the level of zinc in
erythrocytes, but not in plasma, differs between obese
individuals and non-obese controls [55]. The serum zinc
level must be interpreted with caution and is not gener-
ally considered to be a reliable biomarker of zinc status,
but is often the only available measurement [34].
Conclusion
In summary, the gene expression of ZIP14, a zinc and iron
importer, is reversibly down-regulated in adipose tissue in
chronic obesity and is inversely linked to several clinical
markers of lipid and glucose homeostasis. Furthermore,
gene expression of ZIP14 is linked with adipogenesis, as
suggested by its correlation with gene expression of the
adipogenic transcription factor PPARγ. No PPARγ-binding
motifs were found in the promoter sequence of ZIP14; and
we suggest that the connection between ZIP14 and PPARγ
could be linked to the zinc-importing functions of ZIP14
during adipogenesis although a contribution from inflam-
matory cytokines cannot be excluded. We speculate that
ZIP14 could prove to be not only a new biomarker of
metabolic stress but possibly a future medical target in the
treatment of obesity, affecting intracellular zinc regulation
and adipogenesis and thereby supporting a healthy adipose
tissue expansion.
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(HPRT), and ubiquitin conjugase-7 (UBC-7) were used as housekeeping
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